Wednesday, February 14, 2018
DEA creates new resource to help distributors avoid oversupplying opioids
FEB 14 (WASHINGTON)
The U.S. Drug Enforcement Administration has launched a new tool to assist drug manufacturers and distributors with their regulatory obligations under the Controlled Substances Act. This new resource is an example of the many ways DEA is working collaboratively with its 1.73 million registrants to combat the ongoing opioid epidemic in the United States.